Scopis® GmbH (based in Berlin, Germany) develops and manufactures surgical planning and navigation systems for ENT, maxillofacial, neuro and spine surgery.
Scopis Target Guide Surgery (TGS®) is a unique “next-generation” solution for navigated endoscopic surgery that offers surgeons highly advanced image guidance and visualization capabilities using Augmented Reality. Scopis TGS® is provided by the Scopis Hybrid Navigation® system that is the first clinical navigation platform that offers electromagnetic, optical and simultaneous hybrid tracking technology in a single integrated control unit.
Scopis is the leader in medical Augmented Reality (AR). As only company worldwide Scopis offers the Augmented Reality for endoscopic and microscopic procedures.
Scopis operates in over 50 countries and has installed over 300 systems in operation theaters worldwide.